[Short version of the German S3 guideline for bladder cancer]

Urologe A. 2016 Sep;55(9):1173-87. doi: 10.1007/s00120-016-0195-1.
[Article in German]

Abstract

Urinary bladder cancer is the second most common cancer of the urogenital system. The Guideline Program in Oncology (Leitlinienprogramm Onkologie) of the Association of the Scientific Medical Societies in Germany (Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften, AWMF), the German Cancer Society (Deutsche Krebsgesellschaft) and the German Cancer Aid (Deutsche Krebshilfe) as well as 31 different medical societies have developed the first interdisciplinary, evidence-based German guideline for bladder cancer. This short version presents the resulting series of diagnostic and therapeutic recommendations which were based on a systematic literature search and approved by a team of bladder cancer experts. The full version is available under http://leitlinienprogramm-onkologie.de/ .

Keywords: Cystectomy, radical; Grading of recommendations; Guideline program; Level of evidence; Meta-analysis.

Publication types

  • Meta-Analysis
  • Review

MeSH terms

  • Antineoplastic Agents / therapeutic use
  • Combined Modality Therapy / methods
  • Cystectomy / methods*
  • Evidence-Based Medicine
  • Germany
  • Guideline Adherence / standards
  • Humans
  • Medical Oncology / standards*
  • Practice Guidelines as Topic*
  • Quality Assurance, Health Care / standards
  • Quality Control
  • Treatment Outcome
  • Urinary Bladder Neoplasms / diagnosis*
  • Urinary Bladder Neoplasms / therapy*
  • Urology / standards*

Substances

  • Antineoplastic Agents